Cikkek nyilvánosan hozzáférhető megbízással - Michael F. EganTovábbi információ
Sehol sem hozzáférhető: 1
Magnitude of impact of executive functioning and IQ on episodic memory in schizophrenia
BE Kopald, KM Mirra, MF Egan, DR Weinberger, TE Goldberg
Biological psychiatry 71 (6), 545-551, 2012
Megbízások: US National Institutes of Health
Valahol hozzáférhető: 24
Randomized trial of verubecestat for mild-to-moderate Alzheimer’s disease
MF Egan, J Kost, PN Tariot, PS Aisen, JL Cummings, B Vellas, C Sur, ...
New England Journal of Medicine 378 (18), 1691-1703, 2018
Megbízások: US National Institutes of Health
Randomized trial of verubecestat for prodromal Alzheimer’s disease
MF Egan, J Kost, T Voss, Y Mukai, PS Aisen, JL Cummings, PN Tariot, ...
New England Journal of Medicine 380 (15), 1408-1420, 2019
Megbízások: US National Institutes of Health
Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression
L Pezawas, A Meyer-Lindenberg, AL Goldman, BA Verchinski, G Chen, ...
Molecular psychiatry 13 (7), 709-716, 2008
Megbízások: US National Institutes of Health
A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia
SJ Huffaker, J Chen, KK Nicodemus, F Sambataro, F Yang, V Mattay, ...
Nature medicine 15 (5), 509-518, 2009
Megbízások: US National Institutes of Health
Convergence of placenta biology and genetic risk for schizophrenia
G Ursini, G Punzi, Q Chen, S Marenco, JF Robinson, A Porcelli, ...
Nature medicine 24 (6), 792-801, 2018
Megbízások: US National Institutes of Health, German Research Foundation
Set-shifting ability and schizophrenia: a marker of clinical illness or an intermediate phenotype?
AE Ceaser, TE Goldberg, MF Egan, RP McMahon, DR Weinberger, ...
Biological psychiatry 64 (9), 782-788, 2008
Megbízások: US National Institutes of Health
False positives in imaging genetics
A Meyer-Lindenberg, KK Nicodemus, MF Egan, JH Callicott, V Mattay, ...
Neuroimage 40 (2), 655-661, 2008
Megbízások: US National Institutes of Health
Functional Polymorphisms in PRODH Are Associated with Risk and Protection for Schizophrenia and Fronto-Striatal Structure and Function
L Kempf, KK Nicodemus, B Kolachana, R Vakkalanka, BA Verchinski, ...
PLoS genetics 4 (11), e1000252, 2008
Megbízások: US National Institutes of Health
Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder
M Hornig, T Briese, J Licinio, RF Khabbaz, LL Altshuler, SG Potkin, ...
Molecular psychiatry 17 (5), 486-493, 2012
Megbízások: US National Institutes of Health
Verbal and visual memory: characterizing the clinical and intermediate phenotype in schizophrenia
SL Skelley, TE Goldberg, MF Egan, DR Weinberger, JM Gold
Schizophrenia research 105 (1-3), 78-85, 2008
Megbízások: US National Institutes of Health
Neural correlates of probabilistic category learning in patients with schizophrenia
TW Weickert, TE Goldberg, JH Callicott, Q Chen, JA Apud, S Das, ...
Journal of Neuroscience 29 (4), 1244-1254, 2009
Megbízások: US National Institutes of Health
BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer’s disease brain
C Sur, J Kost, D Scott, K Adamczuk, NC Fox, JL Cummings, PN Tariot, ...
Brain 143 (12), 3816-3826, 2020
Megbízások: US National Institutes of Health, UK Medical Research Council, National …
Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer’s disease
MF Egan, Y Mukai, T Voss, J Kost, J Stone, C Furtek, E Mahoney, ...
Alzheimer's research & therapy 11, 1-12, 2019
Megbízások: US National Institutes of Health
Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease
AM Wessels, C Lines, RA Stern, J Kost, T Voss, LH Mozley, C Furtek, ...
Alzheimer's & Dementia 16 (11), 1483-1492, 2020
Megbízások: US National Institutes of Health
Randomized, controlled, proof-of-concept trial of MK-7622 in Alzheimer's disease
T Voss, J Li, J Cummings, M Farlow, C Assaid, S Froman, ...
Alzheimer's & Dementia: Translational Research & Clinical Interventions 4 …, 2018
Megbízások: US National Institutes of Health
Enuresis as a premorbid developmental marker of schizophrenia
TM Hyde, A Deep-Soboslay, B Iglesias, JH Callicott, JM Gold, ...
Brain 131 (9), 2489-2498, 2008
Megbízások: US National Institutes of Health
The Premorbid Adjustment Scale as a measure of developmental compromise in patients with schizophrenia and their healthy siblings
DI Shapiro, S Marenco, EH Spoor, MF Egan, DR Weinberger, JM Gold
Schizophrenia Research 112 (1-3), 136-142, 2009
Megbízások: US National Institutes of Health
Relative risk of probabilistic category learning deficits in patients with schizophrenia and their siblings
TW Weickert, TE Goldberg, MF Egan, JA Apud, M Meeter, CE Myers, ...
Biological Psychiatry 67 (10), 948-955, 2010
Megbízások: US National Institutes of Health
Dopaminergic therapy removal differentially effects learning in schizophrenia and Parkinson’s disease
TW Weickert, VS Mattay, S Das, LB Bigelow, JA Apud, MF Egan, ...
Schizophrenia research 149 (1-3), 162-166, 2013
Megbízások: US National Institutes of Health
A publikációs és a finanszírozási adatokat számítógépes program határozza meg, automatikusan.